Cefpodoxime

Visa No.: 893110242100

Product: Cepoxitil 200

API: Cefpodoxime

Product Category: Antibiotics

Version approved leaflet: 29348e/QLD-ĐK_20/08/2025

INDICATIONS

CEPOXITIL is indicated for the short-term treatment of lower respiratory tract infections caused by susceptible bacteria, including:

• Acute exacerbations of chronic bronchitis
• Community-acquired pneumonia
• Acute sinusitis
• Acute otitis media
• Treatment of uncomplicated infections of  the urethra or rectum in women, and uncomplicated urethral infections in men
• Mild to moderate skin and soft tissue infections
   

DOSAGE AND ADMINISTRATION

CEPOXITIL is for oral administration and should be taken with meals and plenty of water.

• Adults and children ≥ 13 years:
• Community-acquired pneumonia and acute exacerbation of chronic bronchitis: Cefpodoxime 200 mg per dose, every 12 hours, for 10–14 days
• Mild to moderate skin and soft tissue infections: Cefpodoxime 400 mg per dose, every 12 hours, for 7–14 days
• Treatment of uncomplicated urethral infections in men and women, and rectal and endocervical infections in women:
• A single dose of cefpodoxime 200 mg, followed by doxycycline therapy to prevent Chlamydia infection.
• Elderly patients: No dose adjustment is required in elderly patients with normal renal function.
• Children aged 5 months to 12 years: Acute otitis media:Cefpodoxime 5 mg/kg (maximum 200 mg) every 12 hours, or 10 mg/kg (maximum 400 mg) once daily, for 10 days.
• Dosage adjustment in renal impairment:
• Dose reduction is required according to the degree of renal impairment. In patients with creatinine clearance < 30 ml/min and not undergoing hemodialysis: administer the usual dose every 24 hours.
• In patients undergoing hemodialysis: administer the usual dose 3 times per week.
   

CONTRAINDICATIONS

Hypersensitivity to cephalosporins
Patients with disorders of porphyrin metabolism
 

WARNINGS AND PRECAUTIONS

This medicine should be used only under medical supervision.
Carefully read the instructions before use.
If further information is required, consult a physician or pharmacist.
Keep out of reach of children.